Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Termination of Early Pregnancy in Scarred Uterus With Letrozole and Misoprostol Compared to Misoprostol Alone

NCT05067309 is registered in ClinicalTrials.gov with Ahmed Elsayed Aref as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05067309 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Termination of Early Pregnancy in Scarred Uterus With Letrozole and Misoprostol Compared to Misoprostol Alone
Lead sponsor
Ahmed Elsayed Aref
Phase
Observational
Overall status
Unknown status
Start date
October 1, 2021
Completion date
August 1, 2022
Enrollment
1 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

termination of early pregnancy in scarred uterus